US OptionsDetailed Quotes

WST241018C350000

Watchlist

0.50
0.000.00%

15min DelayClose Sep 27 15:59 ET

0.00High0.00Low

West Pharmaceutical Services Stock Discussion

The Thinker

Sep 18 19:43

Market Sentiment Wavers as Bursa Malaysia, U.S. Stocks Decline Amid Fed Cut

CLICK HERE: TYNKR LAB™
Both the U.S. and Bursa Malaysia markets experienced volatility amidst global economic uncertainty and investor caution ahead of the U.S. Federal Reserve’s expected interest rate cut. While the U.S. stock market saw declines, Bursa Malaysia ended lower as well, with losses driven by various sectoral pressures.
U.S. Stock Market
Performance Overview
U.S. equities closed lower on Wednesday, with $Dow Jones Industrial Average (.DJI.US)$ falling b...

Aggressive 50bp rate cut: How long will the market frenzy last?

Stock_Drift

Jun 22 15:53

$West Pharmaceutical Services (WST.US)$

Moomoo Recap US

Feb 15 15:36

Columns Wall Street Today | S&P Makes Another Record After Soft Retail Before Inflation Friday

RECAP
U.S. equity indexes rose after Thursday, with the $Nasdaq Composite Index (.IXIC.US)$ lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week.
The $S&P 500 Index (.SPX.US)$ rose 0.58% to 5,029, a new closing high with the $Dow Jones Industrial Average (.DJI.US)$ up 0.91% to 38,664. The $Nasdaq Composite Index (.IXIC.US)$ was moderately higher at 15,906, af...

Moomoo AI

Feb 15 09:09

Analysts worry about the company's shifting tone and the enduring effect of clients' inventory management on West's finances. Doubts also arise about the company's demand visibility and if current trends suggest a fundamental issue in West's base business.

West Pharmaceutical Stock Tumbles on Weak 2024 Outlook -- Barrons.com

Moomoo AI

Feb 11 11:09

Jefferies analyst David Windley sees FDA approvals of GLP-1s for obesity treatment as a huge opportunity for the manufacturing supply chain. He also notes high rivalry in the injectable fill/finish market. Windley upgraded West Pharmaceutical to Buy, raising its price target by 66% to $536, citing its global footprint and capacity to meet growing GLP-1s demand.

Booming Weight-loss Drug Market to Lift "pick-and-shovel" Plays: Jefferies

Moomoo AI

Feb 7 12:02

The market sentiment around West Pharmaceutical Services hasn't changed much over the past five years, with the share price seemingly reacting to the EPS. The recent improvement in TSR could indicate that the business is getting better with time.

West Pharmaceutical Services (NYSE:WST) Jumps 6.8% This Week, Though Earnings Growth Is Still Tracking Behind Five-year Shareholder Returns

Moomoo AI

Feb 6 13:10

The 4- and 5-star rated Dividend Aristocrats for 2024 include Abbott Laboratories, AbbVie Inc., Air Products & Chemicals, and others such as Coca-Cola Co., McDonald's Corp., Walmart Inc., and West Pharmaceuticals.

4- and 5-Star Rated "Dividend Aristocrat" Stocks for 2024 by CFRA

moom lives

Jan 12 02:57

15 Best performing S&P 500 stocks in the 20 last years:

1. $Apple (AAPL.US)$ : +59,918% (20 year total return)
2. $Monster Beverage (MNST.US)$ : +59,299%
3. $NVIDIA (NVDA.US)$ : +28,712%
4. $Intuitive Machines (LUNR.US)$: +18,221%
5. $Booking Holdings (BKNG.US)$ : +16,299%
6. $Netflix (NFLX.US)$ : +13,442%
7. $Old Dominion Freight Line (ODFL.US)$ : +9,403%
8. $SBA Communications Corp (SBAC.US)$ : +7,356%
9. $Copart (CPRT.US)$ : +6,592%
10. $Regeneron Pharmaceuticals (REGN.US)$ : +6,296%
11. $Amazon (AMZN.US)$ ...

Hail to the new king: Microsoft overtakes Apple as world's most valuable company

Moomoo AI

Dec 27, 2023 10:00

There's a gap between West Pharmaceutical Services' high P/E ratio and its forecasted market-matching growth. Investors appear more bullish than analysts, but this earnings growth level could impact share price, making the high share price difficult to justify.

West Pharmaceutical Services, Inc.'s (NYSE:WST) Business Is Trailing The Market But Its Shares Aren't

Moomoo AI

Dec 6, 2023 08:50

West Pharmaceutical Services, with its surplus and larger cash amount than debt, has a conservative balance sheet, indicating an ability to easily eliminate debt. With a free cash flow being 53% of EBIT, the company is in a strong position to pay down debt when needed.

Does West Pharmaceutical Services (NYSE:WST) Have A Healthy Balance Sheet?

No comment yet